title: [Surgical treatment of stage III-IV ovarian cancer].
abstract: A residual tumor after primary cytoreductive surgery is one of the most important factors of survival of patient with advanced ovarian cancer. Maximal cytoreduction can be achieved by different ways. We studied results of extended, combined and standard operations on patients treated in the Russian Cancer Research Center of the Russian Academy of Medical Sciences in 1989-1999. It was found that only optimal cytoreduction resulted in the absence of recurrences and better overall survival of the patients independent of the operation type (extended, combined or standard).
authors.forename: A I
authors.initials: AI
authors.lastname: Berishvili
authors.forename: V V
authors.initials: VV
authors.lastname: Kuznetsov
authors.forename: V A
authors.initials: VA
authors.lastname: Gorbunova
authors.forename: A G
authors.initials: AG
authors.lastname: Bliumenberg
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D016019:Survival Analysis
vernacular_title: Khirurgicheskoe lechenie raka iaichnikov III-IV stadii.